NO976112D0 - 1,6-disubstituerte isokromaner for behandling av migrene - Google Patents
1,6-disubstituerte isokromaner for behandling av migreneInfo
- Publication number
- NO976112D0 NO976112D0 NO976112A NO976112A NO976112D0 NO 976112 D0 NO976112 D0 NO 976112D0 NO 976112 A NO976112 A NO 976112A NO 976112 A NO976112 A NO 976112A NO 976112 D0 NO976112 D0 NO 976112D0
- Authority
- NO
- Norway
- Prior art keywords
- isochromes
- migraine
- disubstituted
- treatment
- disubstituted isochromes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/76—Benzo[c]pyrans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US74195P | 1995-06-30 | 1995-06-30 | |
| US1123496P | 1996-02-06 | 1996-02-06 | |
| PCT/US1996/008681 WO1997002259A1 (en) | 1995-06-30 | 1996-06-07 | 1,6-disubstituted isochromans for treatment of migraine headaches |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO976112D0 true NO976112D0 (no) | 1997-12-29 |
| NO976112L NO976112L (no) | 1998-03-02 |
Family
ID=26668092
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO976112A NO976112L (no) | 1995-06-30 | 1997-12-29 | 1,6-disubstituerte isokromaner for behandling av migrene |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0836599A1 (no) |
| JP (1) | JPH11509532A (no) |
| AU (1) | AU6252296A (no) |
| BR (1) | BR9609631A (no) |
| CA (1) | CA2225282A1 (no) |
| CZ (1) | CZ418597A3 (no) |
| FI (1) | FI974640A7 (no) |
| MX (1) | MX9710260A (no) |
| NO (1) | NO976112L (no) |
| PL (1) | PL324319A1 (no) |
| SK (1) | SK164297A3 (no) |
| WO (1) | WO1997002259A1 (no) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2370270A (en) * | 2000-12-20 | 2002-06-26 | Lilly Co Eli | Pharmaceutical compounds |
| US7335660B2 (en) | 2001-12-19 | 2008-02-26 | Eli Lilly And Company | Isochroman compounds for treatment of CNS disorders |
| GB0130339D0 (en) * | 2001-12-19 | 2002-02-06 | Lilly Co Eli | Isochroman compounds |
| US7110576B2 (en) | 2002-12-30 | 2006-09-19 | Pitney Bowes Inc. | System and method for authenticating a mailpiece sender |
| RU2372344C2 (ru) | 2004-05-05 | 2009-11-10 | Ф. Хоффманн-Ля Рош Аг | Арилсульфонилбензодиоксаны, применяемые для модуляции 5-нт6 рецептора, 5-нт2a рецептора или и того, и другого |
| WO2006066756A1 (en) | 2004-12-21 | 2006-06-29 | F. Hoffmann-La Roche Ag | Chroman derivatives and uses thereof in the treatment of cns disorders |
| ATE409179T1 (de) | 2004-12-21 | 2008-10-15 | Hoffmann La Roche | Tetralin- und indanderivate und deren anwendungen als 5-ht-antagonisten |
| CN101119965B (zh) | 2004-12-21 | 2012-09-26 | 弗·哈夫曼-拉罗切有限公司 | 萘满和茚满衍生物及其用途 |
| KR100899061B1 (ko) | 2004-12-21 | 2009-05-25 | 에프. 호프만-라 로슈 아게 | 테트랄린 및 인단 유도체 및 이의 용도 |
| KR20070088798A (ko) | 2004-12-21 | 2007-08-29 | 에프. 호프만-라 로슈 아게 | 크로만 유도체 및 그의 5-ht 수용체 리간드로서의 용도 |
| CN101300246A (zh) | 2005-11-03 | 2008-11-05 | 弗·哈夫曼-拉罗切有限公司 | 作为5-ht6抑制剂的芳基磺酰基色满类化合物作为蛋白激酶抑制剂的吲哚基马来酰亚胺衍生物 |
| JP2009541249A (ja) | 2006-06-20 | 2009-11-26 | エフ.ホフマン−ラ ロシュ アーゲー | アリールスルホニルナフタレン誘導体およびその使用 |
| WO2007147762A1 (en) | 2006-06-20 | 2007-12-27 | F. Hoffmann-La Roche Ag | Arylsulfonamidyl tetralin derivatives and uses thereof |
| MX2008015843A (es) | 2006-06-20 | 2009-01-09 | Hoffmann La Roche | Derivados de tetralina e indano y usos de los mismos. |
| EP2404897A4 (en) * | 2009-03-05 | 2014-02-26 | Sumitomo Chemical Co | PROCESS FOR PREPARING HALOGEN-SUBSTITUTED BENCHENETIMETHANOL |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1552004A (en) * | 1976-05-26 | 1979-09-05 | Takeda Chemical Industries Ltd | Isochroman derivatives |
| DE69419778T2 (de) * | 1993-12-28 | 1999-12-09 | Pharmacia & Upjohn Co., Kalamazoo | Heterozyklische verbindungen für die behandlung von kardiovaskular- und zentralnervensystem störungen |
-
1996
- 1996-06-07 PL PL96324319A patent/PL324319A1/xx unknown
- 1996-06-07 BR BR9609631A patent/BR9609631A/pt not_active Application Discontinuation
- 1996-06-07 CA CA002225282A patent/CA2225282A1/en not_active Abandoned
- 1996-06-07 JP JP9505135A patent/JPH11509532A/ja active Pending
- 1996-06-07 AU AU62522/96A patent/AU6252296A/en not_active Abandoned
- 1996-06-07 CZ CZ974185A patent/CZ418597A3/cs unknown
- 1996-06-07 SK SK1642-97A patent/SK164297A3/sk unknown
- 1996-06-07 FI FI974640A patent/FI974640A7/fi unknown
- 1996-06-07 MX MX9710260A patent/MX9710260A/es unknown
- 1996-06-07 WO PCT/US1996/008681 patent/WO1997002259A1/en not_active Ceased
- 1996-06-07 EP EP96921264A patent/EP0836599A1/en not_active Withdrawn
-
1997
- 1997-12-29 NO NO976112A patent/NO976112L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0836599A1 (en) | 1998-04-22 |
| NO976112L (no) | 1998-03-02 |
| SK164297A3 (en) | 1998-09-09 |
| FI974640L (fi) | 1997-12-30 |
| WO1997002259A1 (en) | 1997-01-23 |
| FI974640A0 (fi) | 1997-12-30 |
| AU6252296A (en) | 1997-02-05 |
| FI974640A7 (fi) | 1997-12-30 |
| CZ418597A3 (cs) | 1998-06-17 |
| CA2225282A1 (en) | 1997-01-23 |
| MX9710260A (es) | 1998-03-29 |
| PL324319A1 (en) | 1998-05-25 |
| BR9609631A (pt) | 1999-03-02 |
| JPH11509532A (ja) | 1999-08-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO981800D0 (no) | FremgangsmÕte for fremstilling av 1,1,1,3,3-pentafluorpentan | |
| NO961483D0 (no) | Fremgangsmåte for behandling av oljeholdig formasjon | |
| FI974640L (fi) | Migreenin hoitoon tarkoitetut 1,6-disubstituoidut isokromaanit | |
| ITTO940748A0 (it) | Condotto protesico particolarmente per il trattamento di patologie cardiovascolari. | |
| HUP0004085A3 (en) | Novel 3,6-hemiketals from the class of 9a-azalides | |
| FI20011433L (fi) | Menetelmä 2,5,diamino-4,6-diklooripyrimidiinin valmistamiseksi | |
| IT1292552B1 (it) | Dispositivo per l'applicazione di rivestimenti. | |
| FI973173A0 (fi) | Menetelmä kondensaatin käsittelemiseksi | |
| DK0815092T3 (da) | Fremgangsmåde til fremstilling af 1,2-benzisothiazolin-3-oner | |
| NO985535D0 (no) | FremgangsmÕte for fremstilling av 1,3-alkandioler | |
| NO973366D0 (no) | Fremgangsmåte for behandling av multippel sklerose | |
| NO960307D0 (no) | Fremgangsmåte ved fremstilling av substituerte 4,6-diamino-5-cyanopyrimidiner | |
| NO179101C (no) | Fremgangsmåte for fremstilling av dibeskyttet 2,3-hydroksymetyl-cyklobutanol | |
| FI964829A0 (fi) | Menetelmä 2,2,4-trimetyyli-1,3-pentaanidioli-isobutyraatin valmistamiseksi | |
| FI930237A7 (fi) | Menetelmä 4,6-dialkoksipyrimidiinien valmistamiseksi | |
| EP0579077A3 (en) | 1,3,4-thiadiazinones for the treatment of cardiovascular diseases | |
| DK0783491T3 (da) | Fremgangsmåde til fremstilling af 3,3,5-trichlorglutarimid | |
| NO962812D0 (no) | Fremgangsmåte for behandling av nervebetennelse | |
| FI954263A0 (fi) | Vid skjutning anvaendbart foerfarande foer bestaemning av traeffar | |
| FI951660A0 (fi) | Foerfarande foer undersoekning av virkes fuktighet | |
| FI954795A0 (fi) | Foerfarande foer oekning av en pannas verkningsgrad | |
| RU95117268A (ru) | Средство для лечения атопического дерматита | |
| FI940088A0 (fi) | Regleranordning/reglerdel foer spolvattenmnaengden i en vattenklosett | |
| FI20040505A7 (fi) | Menetelmä 1,3-dihydro-6-hydroksi-2H-indol-2-oni-johdannaisten valmistamiseksi | |
| DK0737068T3 (da) | 2,3-diaryl-1-benzopyraner til behandling af dermatitis |